Nelson Labs Unveils Rapid Sterility Testing to Speed Up Results Nelson Labs, a Sotera Health company, has launched an innovative solution for product-sterility testing through rapid microbiological methods (RMMs) at three of its laboratory sites in the United States and…
iMH Launches First Private Mental Health Hospital in Queensland Queensland’s first private mental health hospital, Nundah Private Hospital, has officially opened, addressing significant gaps in Australia’s mental health system. Operated under a joint venture between Aurora Healthcare and Amplar Health,…
Baxter Launches Voalte Linq Device with Scotty Assistant at HIMSS25 Baxter International Inc. (NYSE: BAX), a global leader in medical technology, unveiled its Voalte Linq device powered by the Scotty assistant at the 2025 HIMSS Global Healthcare Conference. The Voalte…
Peach State Health Plan and Centene Foundation Invest in Atlanta Housing Development Peach State Health Plan, a care management organization serving residents across Georgia, and the Centene Foundation, the philanthropic arm of Centene Corporation, have announced their partnership with Atlanta…
Wellvana Purchases CVS Health’s MSSP Business Wellvana, a leader in value-based care enablement, has announced the acquisition of CVS Health’s Medicare Shared Savings Program (MSSP) business. The deal, an all-stock transaction, also provides CVS Health with a strategic minority stake…
Bunkerhill Health and Cleerly Partner to Enhance Noninvasive Cardiovascular Care Bunkerhill Health, a leader in AI-driven early disease detection, has partnered with Cleerly, a pioneer in advanced cardiovascular imaging, to expand access to their technologies for detecting coronary artery disease…
FDA Accepts Gazyva sBLA for Lupus Nephritis Treatment Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Gazyva® (obinutuzumab) in the treatment of lupus…
New Data Supports DNA Vaccine Delivery via Vaxxas’ HD-MAP Technology Vaxxas, a clinical-stage biotechnology company specializing in a novel vaccination platform, announced today the publication of data validating the effectiveness of its high-density microarray patch (HD-MAP) technology for delivering nucleic…
Allurion Announces New U.S. Patents for Next-Gen Weight Loss Device Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, announced today that it has received two Issue Notifications from the U.S. Patent and Trademark Office (USPTO) for its…
GeneDx Expands Exome and Genome Testing to Include Cerebral Palsy GeneDx (Nasdaq: WGS), a leader in providing genomic insights to enhance health outcomes, announced today the expansion of its genetic testing services to include cerebral palsy (CP). In celebration of…
GE HealthCare Unveils Genesis Portfolio to Accelerate Digital Innovation Adoption GE HealthCare (Nasdaq: GEHC) has announced the launch of its new Genesis solutions, a comprehensive portfolio of cloud-based enterprise imaging software-as-a-service (SaaS) offerings. When commercially released, Genesis will feature four…
Cadrenal Therapeutics Partners with Abbott for Tecarfarin Pivotal Study in HeartMate 3™ LVAD Patients Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company specializing in cardiovascular therapeutics, has announced the signing of a Collaboration Agreement with Abbott (NYSE: ABT). This partnership…